Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
NCT02610712
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Depressive Disorder, Treatment-Resistant
Interventions
DRUG:
Ketamine
Sponsor
National Institute of Neurology and Neurosurgery, Mexico